Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis - Pilot Phase (ATTEST).

Trial Profile

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis - Pilot Phase (ATTEST).

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Tenecteplase (Primary) ; Alteplase
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions
  • Acronyms ATTEST
  • Most Recent Events

    • 13 Dec 2016 Results of pooled post-hoc analysis from TAAIS and ATTEST studies (n=146) published in the Circulation.
    • 22 Feb 2016 Status changed from active, no longer recruiting to completed, as reported by United Kingdom Clinical Research Network.
    • 29 Oct 2015 Results sub-group analysis (n=30) assessing Coagulation and Fibrinolytic Activity published in the Stroke
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top